TradingView
RocketTickers
14 Ağu 2018 16:50
Motif Bio Announces FDA Acceptance of New Drug Application with
Alış
NASDAQ:MTFB
Açıklama
⋅
14 Ağu 2018 16:50
MTFB: Motif Bio plc
2018-08-14 02:00:00
Motif Bio Announces FDA Acceptance of New Drug Application with Priority Review for Iclaprim for Treatment of Acute Bacterial Skin and Skin Structure Infections
Beyond Technical Analysis
Daha Fazla